163 related articles for article (PubMed ID: 34091990)
41. Serial transplantation reveals a critical role for endoglin in hematopoietic stem cell quiescence.
Borges L; Oliveira VKP; Baik J; Bendall SC; Perlingeiro RCR
Blood; 2019 Feb; 133(7):688-696. PubMed ID: 30593445
[TBL] [Abstract][Full Text] [Related]
42. Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.
Nishida J; Miyazono K; Ehata S
Oncogene; 2018 Apr; 37(16):2197-2212. PubMed ID: 29391598
[TBL] [Abstract][Full Text] [Related]
43. Role of SIRT2 in Regulation of Stemness of Cancer Stem-Like Cells in Renal Cell Carcinoma.
Wei R; He D; Zhang X
Cell Physiol Biochem; 2018; 49(6):2348-2357. PubMed ID: 30261494
[TBL] [Abstract][Full Text] [Related]
44. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
45. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
46. Side population analysis in clear cell renal cell carcinoma.
Huang R; Meens J; Yuzwa S; Ailles L; Ohh M; Robinson CM
Biochem Biophys Res Commun; 2021 Dec; 585():196-202. PubMed ID: 34813980
[TBL] [Abstract][Full Text] [Related]
47. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
[TBL] [Abstract][Full Text] [Related]
48. CFTR dysfunction increases endoglin and TGF-β signaling in airway epithelia.
Nicola T; Kabir FL; Coric T; Wall SB; Zhang W; James M; MacEwen M; Ren C; Halloran B; Ambalavanan N; Harris WT
Physiol Rep; 2019 Feb; 7(4):e13977. PubMed ID: 30806029
[TBL] [Abstract][Full Text] [Related]
49. Soluble endoglin antagonizes Met signaling in spindle carcinoma cells.
del Castillo G; Sánchez-Blanco E; Martín-Villar E; Valbuena-Diez AC; Langa C; Pérez-Gómez E; Renart J; Bernabéu C; Quintanilla M
Carcinogenesis; 2015 Feb; 36(2):212-22. PubMed ID: 25503931
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
[TBL] [Abstract][Full Text] [Related]
51. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
Grange C; Brossa A; Bussolati B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013896
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells.
Takahashi K; Ehata S; Koinuma D; Morishita Y; Soda M; Mano H; Miyazono K
Oncogene; 2018 May; 37(21):2757-2772. PubMed ID: 29511349
[TBL] [Abstract][Full Text] [Related]
53. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
54. High Levels of Soluble Endoglin Induce a Proinflammatory and Oxidative-Stress Phenotype Associated with Preserved NO-Dependent Vasodilatation in Aortas from Mice Fed a High-Fat Diet.
Jezkova K; Rathouska J; Nemeckova I; Fikrova P; Dolezelova E; Varejckova M; Vitverova B; Tysonova K; Serwadczak A; Buczek E; Bernabeu C; Lopez-Novoa JM; Chlopicki S; Nachtigal P
J Vasc Res; 2016; 53(3-4):149-162. PubMed ID: 27721318
[TBL] [Abstract][Full Text] [Related]
55. Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell-Matrix Interactions.
Puerto-Camacho P; Díaz-Martín J; Olmedo-Pelayo J; Bolado-Carrancio A; Salguero-Aranda C; Jordán-Pérez C; Esteban-Medina M; Álamo-Álvarez I; Delgado-Bellido D; Lobo-Selma L; Dopazo J; Sastre A; Alonso J; Grünewald TGP; Bernabeu C; Byron A; Brunton VG; Amaral AT; de Álava E
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955799
[TBL] [Abstract][Full Text] [Related]
56. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
Mavrommatis E; Arslan AD; Sassano A; Hua Y; Kroczynska B; Platanias LC
J Biol Chem; 2013 Nov; 288(46):33006-15. PubMed ID: 24089532
[TBL] [Abstract][Full Text] [Related]
57. MELK is Upregulated in Advanced Clear Cell Renal Cell Carcinoma and Promotes Disease Progression by Phosphorylating PRAS40.
Zhang H; Wei P; Lv W; Han X; Yang J; Qin S; Zhang Y
Cell Transplant; 2019 Dec; 28(1_suppl):37S-50S. PubMed ID: 31813279
[TBL] [Abstract][Full Text] [Related]
58. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
